How Much Did Granulation Technology Raise?
Funding & Key Investors

Granulation Technology has secured $150K in total capital, with its most recent financing round bringing in $150K in a major strategic investment. This significant backing underscores the company's established position in the chemical and pharmaceutical manufacturing sector, particularly in its specialized product development solutions for drug portfolios.

What is Granulation Technology?

Granulation Technology
ManufacturingPharmaceuticalsHealth & Nutrition Products

Granulation Technology, Inc. (GTI) operates as a key player in the chemical and pharmaceutical manufacturing and distribution industry. The company distinguishes itself through its comprehensive product development solutions designed to enhance drug development portfolios. GTI's service offerings span critical areas such as formulation development, analytical development, and manufacturing, all conducted under stringent Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) standards. Leveraging a team of seasoned scientific professionals, GTI caters to a diverse clientele, ranging from emerging small businesses to established Fortune 500 corporations. Their portfolio includes notable FDA-approved medications such as Prednisone, Carisoprodol, and Methocarbamol tablets, highlighting their capability in bringing essential pharmaceutical products to market.

How much funding has Granulation Technology raised?

Granulation Technology has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

Key Investors in Granulation Technology

PPP

Public-Private Partnership

What's next for Granulation Technology?

The recent large-scale, late-stage funding event signals a pivotal moment for Granulation Technology, positioning it for accelerated growth and expanded market reach. This strategic investment is likely to fuel advancements in their specialized drug development solutions, potentially enabling the company to scale its manufacturing capabilities and broaden its portfolio of FDA-approved medications. Future endeavors may include further research and development into novel formulations, enhanced analytical services, and strategic partnerships to solidify its competitive edge in the pharmaceutical and chemical manufacturing landscape. The company's commitment to GLP and GMP standards suggests a continued focus on regulatory compliance and quality assurance as it navigates its next phase of expansion.

See full Granulation Technology company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingMedical Devices & Equipment
Food & BeverageManufacturingRetailGrocery Retail
Industrial Machinery & EquipmentManufacturing
Industrial Machinery & EquipmentManufacturing

Frequently Asked Questions Regarding Granulation Technology Financial Insights

What are the most recent funding rounds that Granulation Technology has completed, and what were the funding rounds?
Granulation Technology has recently completed 1 funding rounds: Debt on Apr 13, 2020.
What is the total amount of funding Granulation Technology has raised to date?
Granulation Technology has raised a total of $150K in funding to date.
How many funding rounds has Granulation Technology completed?
Granulation Technology has completed 1 funding rounds.
How much funding did Granulation Technology raise in its most recent funding round?
Granulation Technology raised $150K in its most recent funding round.
Who are the lead investors in Granulation Technology's latest funding round?
The lead investor in Granulation Technology's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Granulation Technology's history?
The largest funding round in Granulation Technology's history was $150K.
See more information about Granulation Technology